New drugs for residual sleepiness in OSA

Jan A. Hedner

Source: 5th Sleep and Breathing Conference
Number: 73

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Jan A. Hedner. New drugs for residual sleepiness in OSA. 5th Sleep and Breathing Conference

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Residual sleepiness in adequately treated OSA
Source: ERS Conference
Year: 2015

Development of a new scale to evaluate sleepiness in obstructive sleep apnea (OSA): The Barcelona sleepiness scale (BSS)
Source: Annual Congress 2012 - Technology, screening and questionnaires in OSA
Year: 2012

Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea
Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing
Year: 2021


Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea
Source: Sleep and Breathing Conference 2021
Year: 2021



Residual sleepiness in obstructive sleep apnoea: phenotype and related symptoms
Source: Eur Respir J 2011; 37: 98-105
Year: 2011



The use of beta-blockers is not associated with increased daytime sleepiness in patients with obstructive sleep apnoea
Source: International Congress 2019 – Beyond continuous positive airway pressure treatment
Year: 2019

Prevalence of residual sleepiness in patients with optimally treated sleep apnea syndrome (OSAS)
Source: Eur Respir J 2005; 26: Suppl. 49, 724s
Year: 2005

Residual sleepiness in patients with OSA on CPAP
Source: Eur Respir J 2009; 34: 1209
Year: 2009


Prevalence of residual excessive sleepiness in CPAP-treated sleep apnoea patients: the French multicentre study
Source: Eur Respir J 2009; 33: 1062-1067
Year: 2009



Sleep architecture in patients with moderate to severe sleep apnea without daytime sleepiness
Source: Annual Congress 2007 - Clinical applications of noninvasive ventilation
Year: 2007


Long-term efficacy of solriamfetol for excessive sleepiness in narcolepsy or obstructive sleep apnea
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019


Predictors of residual sleepiness in adequately treated obstructive sleep apnoea patients
Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea
Year: 2009


Daytime sleepiness and cardiovascular complications in moderate to severe obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing
Year: 2013


New fatigue scale is reliable and valid in obstructive sleep apnea (OSA) patients
Source: Eur Respir J 2006; 28: Suppl. 50, 646s
Year: 2006

Differences in age of sleep apnea patients with normalized and persistent excessive daytime sleepiness after nCPAP therapy
Source: Annual Congress 2004 - CPAP therapy for OSA
Year: 2004


Differences in the daytime sleepiness between sleep apnoea and hypersomnia patients
Source: Annual Congress 2008 - Assessment of sleep apnoea
Year: 2008

Obstructive sleep apnoea in professional drivers with snoring and daytime sleepiness
Source: Eur Respir J 2004; 24: Suppl. 48, 570s
Year: 2004

The frequency of REM related OSA among patients with mild OSA and the relation between apnea and daytime sleepiness among these patients
Source: Annual Congress 2012 - Sleep apnoea: clinical topics
Year: 2012

The application of the Athens insomnia scale, Pittsburgh sleep quality index and Epworth sleepiness scale in patients with obstructive sleep apnea
Source: Annual Congress 2008 - Assessment of sleep apnoea
Year: 2008